As a result, quinoline-derived small-molecule inhibitors emerged as the most effective FAP inhibitors (FAPIs), and their uses have been advanced to FAP-targeted cancer imaging with positron emission tomography (PET) and single-photon emission computer tomography (SPECT) [12,13]. The gene discussed is FAP; the disease is cancer.